Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 4Breast Neoplasms 3Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Paraproteinemias 1Neoplasms, Plasma Cell 1Lymphoproliferative Disorders 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Leukemia 1Inflammation 1Fatigue 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Brain Neoplasms 1Anus Neoplasms 1

Interventions

Rituximab 5fludarabine 4Tacrolimus 4Epoetin Alfa 4Cyclophosphamide 4Busulfan 4Darbepoetin alfa 3Alemtuzumab 3fludarabine phosphate 2entrectinib 2atezolizumab 2alectinib 2Thiotepa 2Therapeutics 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Methotrexate 2Etoposide 2Early Intervention, Educational 2Cytarabine 2Bortezomib 2Antilymphocyte Serum 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2venetoclax 1trametinib 1tirbanibulin 1sargramostim 1plerixafor 1phenethyl isothiocyanate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoproliferative Disorders × Chromatin Immunoprecipitation Sequencing × Clear all
NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Mayo Clinic

Phase NA Recruiting
82 enrolled
LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡